BAL PHARMA Financial Statement Analysis
|
||
The Revenues of BAL PHARMA have increased by 8.18% YoY .
The Earnings Per Share (EPS) of BAL PHARMA has decreased by -56.73 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
BAL PHARMA Last 5 Annual Financial Results
[BOM: 524824|NSE : BALPHARMA]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹304 Cr | ₹281 Cr | ₹251 Cr | ₹171 Cr | ₹225 Cr |
Expenses | ₹279 Cr | ₹257 Cr | ₹226 Cr | ₹166 Cr | ₹207 Cr |
Operating Profit (Excl OI) | ₹25 Cr | ₹24 Cr | ₹25 Cr | ₹5.03 Cr | ₹18 Cr |
Other Income | ₹0.94 Cr | ₹5.15 Cr | ₹1.14 Cr | ₹1.85 Cr | ₹1.01 Cr |
Interest | ₹12 Cr | ₹11 Cr | ₹12 Cr | ₹13 Cr | ₹13 Cr |
Depreciation | ₹9.13 Cr | ₹9.04 Cr | ₹9.52 Cr | ₹7.68 Cr | ₹6.16 Cr |
Profit Before Tax | ₹4.75 Cr | ₹9.18 Cr | ₹4.10 Cr | ₹-14 Cr | ₹-0.20 Cr |
Profit After Tax | ₹2.62 Cr | ₹5.71 Cr | ₹4.71 Cr | ₹-13 Cr | ₹2.15 Cr |
Consolidated Net Profit | ₹2.57 Cr | ₹5.61 Cr | ₹4.74 Cr | ₹-12 Cr | ₹3.79 Cr |
Earnings Per Share (Rs) | ₹1.64 | ₹3.79 | ₹3.20 | ₹-8.62 | ₹2.67 |
PAT Margin (%) | 0.86 | 2.03 | 1.88 | -7.53 | 0.96 |
ROE(%) | 4.31 | 10.34 | 8.97 | -21.65 | 3.27 |
ROCE(%) | 9.56 | 12.33 | 9.72 | -0.44 | 6.88 |
Total Debt/Equity(x) | 2.05 | 1.80 | 2.09 | 2.26 | 1.85 |
Key Financials |
||
Market Cap | : | ₹ 155.8 Cr |
Revenue (TTM) | : | ₹ 327.0 Cr |
Net Profit(TTM) | : | ₹ 3.5 Cr |
EPS (TTM) | : | ₹ 2.2 |
P/E (TTM) | : | 44.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
BAL PHARMA | -0.5% | -1.3% | 25.1% |
SUN PHARMACEUTICAL INDUSTRIES | 0.9% | -6.6% | 58.8% |
CIPLA | -1% | -5.6% | 54.6% |
DR REDDYS LABORATORIES | 0.9% | 2.2% | 27.3% |
ZYDUS LIFESCIENCES | 2.8% | -0.6% | 96.2% |
DIVIS LABORATORIES | -2.2% | 6.2% | 21.2% |
MANKIND PHARMA | -6.3% | -5% | NA |
TORRENT PHARMACEUTICALS | -0.9% | 1.1% | 64.2% |
LUPIN | -2.1% | 0.4% | 137.2% |
BAL PHARMA Revenues
[BOM: 524824|NSE : BALPHARMA]
Y-o-Y | 8.18 % |
5 Yr CAGR | 7.83 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹304 Cr | 8.18 | |
Mar2022 | ₹281 Cr | 12.25 | |
Mar2021 | ₹251 Cr | 46.43 | |
Mar2020 | ₹171 Cr | -23.96 | |
Mar2019 | ₹225 Cr | - |
BAL PHARMA Operating Profit
[BOM: 524824|NSE : BALPHARMA]
Y-o-Y | 5.30 % |
5 Yr CAGR | 9.31 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹25 Cr | 5.30 | |
Mar2022 | ₹24 Cr | -2.70 | |
Mar2021 | ₹25 Cr | 390.23 | |
Mar2020 | ₹5.03 Cr | -71.57 | |
Mar2019 | ₹18 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -2.70 % |
5 Yr CAGR | 1.37 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 8.3% | -2.70 | |
Mar2022 | 8.53% | -13.31 | |
Mar2021 | 9.84% | 234.69 | |
Mar2020 | 2.94% | -62.60 | |
Mar2019 | 7.86% | - |
BAL PHARMA Profit After Tax
[BOM: 524824|NSE : BALPHARMA]
Y-o-Y | -54.17 % |
5 Yr CAGR | -9.23 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹2.57 Cr | -54.17 | |
Mar2022 | ₹5.61 Cr | 18.35 | |
Mar2021 | ₹4.74 Cr | Positive | |
Mar2020 | ₹-12 Cr | Negative | |
Mar2019 | ₹3.79 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -57.64 % |
5 Yr CAGR | -2.71 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 0.86 % | -57.64 | |
Mar2022 | 2.03 % | 7.98 | |
Mar2021 | 1.88 % | Positive | |
Mar2020 | -7.53 % | Negative | |
Mar2019 | 0.96 % | - |
BAL PHARMA Earnings Per Share (EPS)
[BOM: 524824|NSE : BALPHARMA]
Y-o-Y | -56.73 % |
5 Yr CAGR | -11.47 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹1.64 | -56.73 | |
Mar2022 | ₹3.79 | 18.44 | |
Mar2021 | ₹3.20 | Positive | |
Mar2020 | ₹-8.62 | Negative | |
Mar2019 | ₹2.67 | - |
BAL PHARMA Return on Capital Employed (ROCE)
[BOM: 524824|NSE : BALPHARMA]
Y-o-Y | -22.47 % |
5 Yr CAGR | 8.57 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 9.56% | -22.47 | |
Mar2022 | 12.33% | 26.85 | |
Mar2021 | 9.72% | Positive | |
Mar2020 | -0.44% | Negative | |
Mar2019 | 6.88% | - |
BAL PHARMA Share Price vs Sensex
Current Share Price | : | ₹98.6 |
Current MarketCap | : | ₹ 155.8 Cr |
Updated EOD on | : | May 07,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -0.5% |
-1.3% |
25.1% |
SENSEX | -1.6% |
-0.5% |
19.8% |
BAL PHARMA related INDICES
You may also like the below Video Courses
FAQ about BAL PHARMA Financials
How the annual revenues of BAL PHARMA have changed ?
The Revenues of BAL PHARMA have increased by 8.18% YoY .
How the Earnings per Share (EPS) of BAL PHARMA have changed?
The Earnings Per Share (EPS) of BAL PHARMA has decreased by -56.73 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs